Wir sind am 01.04. umgezogen! Unsere neue Adresse ist: Reimerstwiete 11, 20457 Hamburg
Stay up to date. Here we inform you regularly about current topics and trends from the pharmaceutical, biotech & medical technology industry and of course all news about Saidia.
What GDP non-compliance reports reveal about structural weaknesses.
An analysis of EMA approval data from key procedures for antineoplastic drugs.
How Modern PV Structures Protect Patients and Empower Companies.
Finally it is online: Our new website! After long planning and hard work we are proud to present our customers and visitors a brand new online presence.
After exciting years at our previous location, it was time for a change.
Infographic on marketing authorization applications for human medicinal products submitted to the EMA between 2019 and 2023
Every pharmaceutical company should consider this important question - and there is only one clear answer.
Dr. Corinna Lender talks about why IFA notification resembles a puzzle game and the challenges it poses in her day-to-day work at Saidia.
Well-established use applications for marketing authorization are becoming increasingly popular in the pharmaceutical industry, but this could soon come to an end with the future EU pharmaceutical package.
Why mandated educational materials may affect the success of medicinal product launches.
©2025 Saidia Pharma Services Germany GmbH. All rights reserved.
%203.svg){kind=logo}